New and novel healthcare solutions: apply for innovation funding

Innovate UK

August 2
10:05 2017

Innovate UK and the Medical Research Council (MRC) are to invest up to 12 million in new and novel healthcare solutions.

There are 2 competitions for UK micro, small and medium-sized enterprises (SMEs) in the latest round of the Biomedical Catalyst. These are for feasibility and early stage projects.

What we are looking for

We are looking to support the development of innovative healthcare technologies and processes such as:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

Feasibility studies

These are for exploring and testing the commercial potential and feasibility of ideas. Up to 2 million is available.

Early-stage projects

These are for testing a well-developed concept and showing its effectiveness in a relevant environment. Up to 10 million is available.

About the Biomedical Catalyst

The Biomedical Catalyst is a partnership between Innovate UK and the MRC. It aims to support the most innovative life sciences opportunities regardless of the scientific approach. It also wants to de-risk academia and industry being able to take forward innovative scientific ideas.

Competition information

  • the competitions are open, and the deadline is midday on Wednesday 11 October 2017
  • you could get up to 200,000 for feasibility studies lasting up to 1 year
  • you could get between 250,000 and 4 million for early-stage projects lasting between 1 and 3 years
  • you can work alone or in collaboration with other businesses or research organisations, but to lead a project you must be a UK-based SME
  • you can watch the recording of the briefing event to help with your application

Find out more and apply for the feasibility studies competition.

Find out more and apply for the early-stage competition.

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: